These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 31252207)
1. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice. Xiao X; Chen Q; Zhu X; Wang Y Neurobiol Aging; 2019 Sep; 81():77-87. PubMed ID: 31252207 [TBL] [Abstract][Full Text] [Related]
2. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease. Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267 [TBL] [Abstract][Full Text] [Related]
4. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model. Zakaria A; Hamdi N; Abdel-Kader RM Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181 [TBL] [Abstract][Full Text] [Related]
5. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice. Wang Y; Tang XC; Zhang HY J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568 [TBL] [Abstract][Full Text] [Related]
6. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549 [TBL] [Abstract][Full Text] [Related]
7. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036 [TBL] [Abstract][Full Text] [Related]
8. Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Wang CY; Zheng W; Wang T; Xie JW; Wang SL; Zhao BL; Teng WP; Wang ZY Neuropsychopharmacology; 2011 Apr; 36(5):1073-89. PubMed ID: 21289607 [TBL] [Abstract][Full Text] [Related]
9. Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. Xiao XQ; Wang R; Tang XC J Neurosci Res; 2000 Sep; 61(5):564-9. PubMed ID: 10956426 [TBL] [Abstract][Full Text] [Related]
10. Involvement of Intracellular and Mitochondrial Aβ in the Ameliorative Effects of Huperzine A against Oligomeric Aβ42-Induced Injury in Primary Rat Neurons. Lei Y; Yang L; Ye CY; Qin MY; Yang HY; Jiang HL; Tang XC; Zhang HY PLoS One; 2015; 10(5):e0128366. PubMed ID: 26024517 [TBL] [Abstract][Full Text] [Related]
11. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A. Yang L; Ye CY; Huang XT; Tang XC; Zhang HY J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease. Morsy A; Trippier PC J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369 [TBL] [Abstract][Full Text] [Related]
13. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro. Ye CY; Lei Y; Tang XC; Zhang HY Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol. Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920 [TBL] [Abstract][Full Text] [Related]
15. Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems. Nepovimova E; Svobodova L; Dolezal R; Hepnarova V; Junova L; Jun D; Korabecny J; Kucera T; Gazova Z; Motykova K; Kubackova J; Bednarikova Z; Janockova J; Jesus C; Cortes L; Pina J; Rostohar D; Serpa C; Soukup O; Aitken L; Hughes RE; Musilek K; Muckova L; Jost P; Chvojkova M; Vales K; Valis M; Chrienova Z; Chalupova K; Kuca K Bioorg Chem; 2021 Feb; 107():104596. PubMed ID: 33421953 [TBL] [Abstract][Full Text] [Related]
16. Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease. He XY; Isaacs C; Yang SY J Alzheimers Dis; 2018; 62(2):665-673. PubMed ID: 29480196 [TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study. He XY; Dobkin C; Brown WT; Yang SY J Alzheimers Dis; 2022; 88(4):1487-1497. PubMed ID: 35786658 [TBL] [Abstract][Full Text] [Related]
18. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease. Friedli MJ; Inestrosa NC Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940 [TBL] [Abstract][Full Text] [Related]
19. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction. Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630 [TBL] [Abstract][Full Text] [Related]
20. Stereoselectivities of enantiomers of huperzine A in protection against beta-amyloid(25-35)-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice. Zhang HY; Liang YQ; Tang XC; He XC; Bai DL Neurosci Lett; 2002 Jan; 317(3):143-6. PubMed ID: 11755260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]